BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2025 7:42:37 AM | Browse: 138 | Download: 355
 |
Received |
|
2025-05-12 12:10 |
|
Peer-Review Started |
|
2025-05-12 12:11 |
|
First Decision by Editorial Office Director |
|
2025-07-04 09:59 |
|
Return for Revision |
|
2025-07-04 10:18 |
|
Revised |
|
2025-07-18 14:56 |
|
Publication Fee Transferred |
|
2025-07-19 14:33 |
|
Second Decision by Editor |
|
2025-09-09 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-09-09 08:12 |
|
Articles in Press |
|
2025-09-09 08:12 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-29 06:12 |
|
Publish the Manuscript Online |
|
2025-10-14 07:42 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Lipid metabolic reprogramming in colorectal cancer: Insights to mechanisms and therapeutics
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chen-Dong Wang, Bi-Xiang Zhang and Jia Song |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jia Song, Associate Professor, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan 430030, Hubei Province, China. tjhsongjia@hust.edu.cn |
| Key Words |
Colorectal cancer; Lipid metabolism reprogramming; High-fat diet; Tumor microenvironment; Targeted drugs |
| Core Tip |
Lipid metabolic reprogramming is a hallmark of colorectal cancer, influencing tumor initiation, immune evasion, and therapeutic resistance. Targeting key nodes in lipid synthesis, oxidation, and transport, particularly in combination with immunotherapy, offers a transformative approach to colorectal cancer treatment. While preclinical models highlight the efficacy of metabolic-immune combinatory regimens, future studies should prioritize clinical translation of these strategies while addressing metabolic heterogeneity and microenvironmental crosstalk. |
| Publish Date |
2025-10-14 07:42 |
| Citation |
Wang CD, Zhang BX, Song J. Lipid metabolic reprogramming in colorectal cancer: Insights to mechanisms and therapeutics. World J Gastrointest Oncol 2025; 17(10): 109398 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i10/109398.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i10.109398 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
